个人信息
Personal information
教授 博士生导师 硕士生导师
所在单位：药学院
学历：研究生(博士)毕业
学位：医学博士学位
毕业院校：同济医科大学
学科：药理学曾获荣誉：
2014 湖北省科技进步奖贰等奖
2021 湖北省科技进步贰等奖
2014 武汉市科技进步奖叁等奖
- [1] Li SL, Zhou H, Liu J, Yang J, Jiang L, Yuan HM, Wang MH, Yang KS, Xiang M*. Restoration of HMGCS2-mediated ketogenesis alleviates tacrolimus-induced hepatic lipid metabolism disorder. Acta Pharmacol Sin. 2024 May 17. doi: 10.1038/s41401-024-01300-0..2024,
- [2] Tian C, Huang R, Xiang M*. SIRT1: Harnessing multiple pathways to hinder NAFLD. Pharmacol Res. 2024 May;203:107155. doi: 10.1016/j.phrs.2024.107155..2024,
- [3] Li S, Yuan H, Yang K, Li Q, Xiang M*. Pancreatic sympathetic innervation disturbance in type 1 diabetes. Clin Immunol. 2023 May;250:109319. doi: 10.1016/j.clim.2023.109319..2023,
- [4] Yang J, He J, Feng Y, Xiang M*. Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. Front Immunol. 2023 May 17;14:1166440. doi: 10.3389/fimmu.2023.1166440..2023,
- [5] Yang J, Li S, He J, Xu Q, Xie M, Yang C, Wang H, Zhang Y, Wan Q, Xiang M*. Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT/Raf-1-dependent pathway in hepatocellular carcinoma. Cell Death Discov. 2023 Apr 28;9(1):139. doi: 10.1038/s41420-023-01405-1..2023,
- [6] Huang R, Wang B, He J, Zhang Z, Xie R, Li S, Li Q, Tian C, Tuo Y, Zheng R, Chen W, Xiang M*. Lian-Qu formula treats metabolic syndrome via reducing fat synthesis, insulin resistance and inflammation. J Ethnopharmacol. 2023 Apr 24;306:116060. doi: 10.1016/j.jep.2022.116060..2023,
- [7] Tian C, Yuan H, Lu Y, He H, Li Q, Li S, Yang J, Wang M, Xu R, Liu Q, Xiang M*. CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport. Oncoimmunology. 2023 Apr 19;12(1):2204015. doi: 10.1080/2162402X.2023.2204015..2023,
- [8] Li Q, He J, Li S, Tian C, Yang J, Yuan H, Lu Y, Fagone P, Nicoletti F, Xiang M*. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway. Clin Immunol. 2023 Mar;248:109217. doi: 10.1016/j.clim.2022.109217..2023,
- [9] Lu Y#, Zhang P#, Chen H, Tong Q, Wang J, Li Q, Tian C, Yang J, Li S, Zhang Z, Yuan H,Xiang M*. Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B. Toxicol Appl Pharmacol.2022 Apr 15;441:115971. doi: 10.1016/j.taap.2022.115971..2022,
- [10] Xiang M*, Liu T, Tian C, Ma K, Gou J, Huang R, Li S, Li Q, Xu C, Li L, Lee CH, Zhang Y. Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway. Pharmacol Res. 2022 Mar;177:106092. doi: 10.1016/j.phrs.2022.106092..2022,